Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system

Journal of Clinical Microbiology

Volumn 46, Issue 12, 2008, Pages 3952-3956

  Martin, Anandi ^a,b   Von Groll, Andrea ^a,c   Fissette, Krista ^a   Palomino, Juan Carlos ^a   Varaine, Francis ^b   Portaels, Françoise ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; ETHIONAMIDE; KANAMYCIN; OFLOXACIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; CONTROLLED STUDY; EVALUATION RESEARCH; ISOLATION PROCEDURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 57349109949     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01171-08     Document Type: Article

References (30)

1. Ardito, F., B. Posteraro, M. Sanguinetti, S. Zanetti, and G. Fadda. 2001. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 39:4440-4444.
2. Barreto, A. M., J. B. Araújo, R. F. de Melo Medeiros, and P. C. de Souza Caldas. 2003. Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system. Mem. Inst. Oswaldo Cruz 98:827-830.
3. Bastian, I., and R. Colebunders. 1999. Treatment and prevention of multidrug-resistant tuberculosis. Drugs 58:633-661.
4. Bastian, I., L. Rigouts, J. C. Palomino, and F. Portaels. 2001. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob. Agents Chemother. 45:1934-1936.
5. Bemer, P., F. Palicova, S. Rüsch-Gerdes, H. B. Drugeon, and G. E. Pfyffer. 2002. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:150-154.
6. Canetti, G., F. Froman, J. Grosset, P. Hauduroy, M. Langerova, H. T. Mahler, G. Meissner, D. A. Mitchison, and L. Sula. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. W. H. O. 29:565-578.
7. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43.
8. Chen, C. H., J. F. Shih, P. J. Lindholm-Levy, and L. B. Heifets. 1989. Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan. Am. Rev. Respir. Dis. 140:987-989.
9. Heifets, L. B., and P. J. Lindholm-Levy. 1987. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68:267-276.
10. Heifets, L. B., P. J. Lindholm-Levy, and M. Flory. 1991. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 143:268-270.
11. Kim, S. J., M. A. Espinal, C. Abe, G. H. Bai, F. Boulahbal, L. Fattorin, C. Gilpin, S. Hoffner, K. M. Kam, N. Martin-Casabona, L. Rigouts, and V. Vincent. 2004. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int. J. Tuberc. Lung Dis. 8:1157-1158.
12. Krüüner, A., M. D. Yates, and F. A. Drobniewski. 2006. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:811-818.
13. Martin, A., J. C. Palomino, and F. Portaels. 2005. Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J. Clin. Microbiol. 43:1612-1616.
14. Martin, A., M. Camacho, F. Portaels, and J. C. Palomino. 2003. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob. Agents Chemother. 47:3616-3619.
15. Mitchison, D. A. 2005. Drug resistance in tuberculosis. Eur. Respir. J. 25:376-379.
16. Morcillo, N., B. Di Giulio, B. Testani, M. Pontino, C. Chirico, and A. Dolmann. 2004. A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents. Int. J. Tuberc. Lung Dis. 8:253-259.
17. NCCLS. 2000. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes. Tentative standard, 2nd ed. NCCLS M24-T2 (ISBN 1-56238-423-6). National Committee for Clinical and Laboratory Standards, Wayne, PA.
18. Palaci, M., S. Y. Ueki, D. N Sato, M. A. Da Silva Telles, M. Curcio, and E. A. Silva. 1996. Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J. Clin. Microbiol. 34:762-764.
19. Palomino, J. C., H. Traore, K. Fissette, and F. Portaels. 1999. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 3:344-348.
20. Pfyffer, G. E., D. A. Bonato, A. Ebrahimzadeh, W. Gross, J. Hotaling, J. Kornblum, A. Laszlo, G. Roberts, M. Salfinger, F. Wittwer, and S. Siddiqi. 1999. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J. Clin. Microbiol. 37:3179-3186.
21. Pracharktam, R., K. Angkananukool, and A. Vibhagool. 2001. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand. J. Med. Assoc. Thai. 84:1241-1245.
22. Rastogi, N., V. Labrousse, and K. S. Goh. 1996. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37 v strain in human macrophages. Curr. Microbiol. 33:167-175.
23. Rüsch-Gerdes, S., C. Domehl, G. Nardi, M. R. Gismondo, H. M. Welscher, and G. E. Pfyffer. 1999. Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J. Clin. Microbiol. 37:45-48.
24. Rüsch-Gerdes, S., G. E. Pfyffer, M. Casal, M. Chadwick, and S. Siddiqi. 2006. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drug and newer antimicrobials. J. Clin. Microbiol. 44:688-692.
25. Scarparo, C., P. Ricordi, G. Ruggiero, and P. Piccoli. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114.
26. Umubyeyi, A. N., A. Martin, G. Zissis, M. Struelens, E. Karita, and F. Portaels. 2006. Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis. Int. J. Tuberc. Lung Dis. 10:808-811.
27. Vannelli, T. A., A. Dykman, and P. R. Ortiz de Montellano. 2002. Antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase. J. Biol. Chem. 277:12824-12829.
28. World Health Organization. 2006. WHO Global Task Force outlines measures to combat XDR-TB worldwide. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/news/notes/2006/np29/en/index.html.
29. World Health Organization. 2007. Strategic and Technical Advisory Group for tuberculosis (STAG-TB). Report on conclusions and recommendations 11 to 13 June 2007. WHO, Geneva, Switzerland.
30. World Health Organization. 2003. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.313. WHO, Geneva, Switzerland.